In addition, Vangl2-deleted MSCs show augmented LAMP2A and CMA levels, with consequent increase in OB differentiation capacity whereas AD differentiation is reduced, thus confirming the role of VANG2L in controlling LAMP2A expression and CMA activity. This evidence concerns the gene VANGL2 and Alzheimer disease.